|
Anti-Tumor Effects of Thymol in Oral Squamous Cell Carcinoma
|
Final Pr. ID: 1404
|
|
Calprotectin (S100A8/A9) Regulates the DNA Damage Repair Pathway in HNSCC
|
Final Pr. ID: 0096
|
|
Combined Rosmarinic Acid-Blue Light Treatment Inhibits Oral Cancer Cell Progression
|
Final Pr. ID: 1414
|
|
Comparative Study of Breast Cancer Cells and Effects of Clinically Used Bisphosphonates, Zelondronic Acid and Alendronate, in 2D Cell Culture and 3D Live Bone Microenvironment
|
Final Pr. ID: 0097
|
|
Does Heat Shock Protein 70 Alter Squamous Cell Carcinoma Development?
|
Final Pr. ID: 1413
|
|
Hypoxia Induces DNA-Repair Protein DDB2 in Oral Cancer
|
Final Pr. ID: 1408
|
|
MiR-375 is Candidate Biomarker for Malignant Transformation in Oral Lesions
|
Final Pr. ID: 1405
|
|
miR126 Vascular Therapeutics: Friend or Foe?
|
Final Pr. ID: 1412
|
|
MMP20 Silencing Inhibits Key Tumorigenic Hallmarks of Oral Cancer
|
Final Pr. ID: 0099
|
|
Oral Cancer Resistance to Target-Therapy: The Effect of PTEN and c-MET Molecular Interaction
|
Final Pr. ID: 0098
|
|
Polygodial Analogs have Anti-Tumor Effects in Oral Squamous Cell Carcinoma that are Independent of TRPV1 Activity
|
Final Pr. ID: 1410
|
|
Predicting the chemo-sensitivity for cisplatin in oral squamous cell carcinoma
|
Final Pr. ID: 1411
|
|
Stromal Configuration by Human Carcinoma Transplantation in Mouse Tongue
|
Final Pr. ID: 1406
|
|
The Role of Fibronectin and Btbd7 in Oral Squamous Cell Carcinoma
|
Final Pr. ID: 1409
|
|
Urokinase Plasminogen Activator (uPA) Activity in OSCC Cell Conditioned Media
|
Final Pr. ID: 1407
|
